Clinical Severity Staging System May Aid Tx Selection for Meniere Disease
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 6, 2023 -- A three-factor, composite clinical severity staging system can optimize treatment selection for the management of Meniere disease, according to a study published online Aug. 25 in Otolaryngology -- Head and Neck Surgery.
Brevin J. Miller, from Washington University in St. Louis, and colleagues sought to identify clinically important factors associated with conservative treatment response in Meniere disease and to develop a composite clinical severity staging system. Seventy-eight patients were enrolled in the study.
The researchers found that 63 percent of patients were responsive to conservative therapies. Higher proportions of no or mild vertigo (24 percent) and none or mild comorbidity (27 percent) and a lower proportion of hearing loss (19 percent) were seen among responsive versus unresponsive patients. A three-stage system that consolidated these factors demonstrated a treatment response gradient ranging from 100 percent for stage 1 (11 patients), 64 percent for stage 2 (56 patients), and 18 percent for stage 3 (11 patients).
"A composite clinical severity staging system including these three factors can be used to optimize treatment selection and promote patient-centered management of Meniere's disease," the authors write.
One author reported being a consultant for Cochlear Ltd.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Breakthrough Gene Therapy Enables Infant Born Deaf to Hear
FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...
Clinical Practice Guideline Developed for Age-Related Hearing Loss
FRIDAY, May 10, 2024 -- In a clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online April 30 in...
Study Compares Vestibular Endolymphatic Hydrops Grading Methods in Meniere Disease
TUESDAY, May 7, 2024 -- In a study published online April 17 in the European Archives of Oto-Rhino-Laryngology, different grading methods for vestibular endolymphatic hydrops (EH)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.